Post-transplant peripheral blood donor-specific IFN-γ ELISPOT assays differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients

Noninvasive diagnosis of kidney allograft inflammation in transplant recipients with stable graft function (subclinical rejection) could permit more effective therapy and prevent later development of de novo anti-donor HLA antibodies and/or graft dysfunction. Here we tested whether quantifying post-...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Kidney Int
Autors principals: Crespo, Elena, Cravedi, Paolo, Martorell, Jaume, Luque, Sergi, Melilli, Edoardo, Cruzado, Josep M, Jarque, Marta, Meneghini, Maria, Manonelles, Anna, Donadei, Chiara, Lloberas, Núria, Gomà, Montse, Grinyó, Josep M, Heeger, Peter, Bestard, Oriol
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5930006/
https://ncbi.nlm.nih.gov/pubmed/28274484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.kint.2016.12.024
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars